GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » West Pharmaceutical Services Inc (NYSE:WST) » Definitions » Cyclically Adjusted FCF per Share

WST (West Pharmaceutical Services) Cyclically Adjusted FCF per Share : $3.89 (As of Mar. 2025)


View and export this data going back to 1973. Start your Free Trial

What is West Pharmaceutical Services Cyclically Adjusted FCF per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

West Pharmaceutical Services's adjusted free cash flow per share for the three months ended in Mar. 2025 was $0.796. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is $3.89 for the trailing ten years ended in Mar. 2025.

During the past 12 months, West Pharmaceutical Services's average Cyclically Adjusted FCF Growth Rate was 11.50% per year. During the past 3 years, the average Cyclically Adjusted FCF Growth Rate was 18.90% per year. During the past 5 years, the average Cyclically Adjusted FCF Growth Rate was 22.80% per year. During the past 10 years, the average Cyclically Adjusted FCF Growth Rate was 23.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of West Pharmaceutical Services was 33.90% per year. The lowest was -10.40% per year. And the median was 14.45% per year.

As of today (2025-07-05), West Pharmaceutical Services's current stock price is $222.26. West Pharmaceutical Services's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2025 was $3.89. West Pharmaceutical Services's Cyclically Adjusted Price-to-FCF of today is 57.14.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of West Pharmaceutical Services was 243.13. The lowest was 51.90. And the median was 116.36.


West Pharmaceutical Services Cyclically Adjusted FCF per Share Historical Data

The historical data trend for West Pharmaceutical Services's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

West Pharmaceutical Services Cyclically Adjusted FCF per Share Chart

West Pharmaceutical Services Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.69 2.20 2.82 3.35 3.70

West Pharmaceutical Services Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.49 3.53 3.61 3.70 3.89

Competitive Comparison of West Pharmaceutical Services's Cyclically Adjusted FCF per Share

For the Medical Instruments & Supplies subindustry, West Pharmaceutical Services's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


West Pharmaceutical Services's Cyclically Adjusted Price-to-FCF Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, West Pharmaceutical Services's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where West Pharmaceutical Services's Cyclically Adjusted Price-to-FCF falls into.


;
;

West Pharmaceutical Services Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, West Pharmaceutical Services's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2025 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=0.796/134.9266*134.9266
=0.796

Current CPI (Mar. 2025) = 134.9266.

West Pharmaceutical Services Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201506 0.689 100.684 0.923
201509 0.529 100.392 0.711
201512 0.312 99.792 0.422
201603 -0.486 100.470 -0.653
201606 0.551 101.688 0.731
201609 0.263 101.861 0.348
201612 0.320 101.863 0.424
201703 -0.224 102.862 -0.294
201706 0.736 103.349 0.961
201709 0.547 104.136 0.709
201712 0.701 104.011 0.909
201803 0.225 105.290 0.288
201806 0.824 106.317 1.046
201809 0.818 106.507 1.036
201812 0.573 105.998 0.729
201903 0.250 107.251 0.315
201906 1.023 108.070 1.277
201909 1.012 108.329 1.260
201912 0.909 108.420 1.131
202003 0.331 108.902 0.410
202006 1.420 108.767 1.762
202009 0.938 109.815 1.152
202012 1.241 109.897 1.524
202103 0.449 111.754 0.542
202106 1.156 114.631 1.361
202109 1.642 115.734 1.914
202112 1.084 117.630 1.243
202203 1.124 121.301 1.250
202206 1.412 125.017 1.524
202209 1.468 125.227 1.582
202212 1.800 125.222 1.940
202303 0.740 127.348 0.784
202306 1.244 128.729 1.304
202309 1.784 129.860 1.854
202312 1.746 129.419 1.820
202403 0.371 131.776 0.380
202406 0.879 132.554 0.895
202409 1.346 133.029 1.365
202412 1.161 133.157 1.176
202503 0.796 134.927 0.796

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.


West Pharmaceutical Services  (NYSE:WST) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

West Pharmaceutical Services's Cyclically Adjusted Price-to-FCF of today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/Cyclically Adjusted FCF per Share
=222.26/3.89
=57.14

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of West Pharmaceutical Services was 243.13. The lowest was 51.90. And the median was 116.36.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


West Pharmaceutical Services Cyclically Adjusted FCF per Share Related Terms

Thank you for viewing the detailed overview of West Pharmaceutical Services's Cyclically Adjusted FCF per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


West Pharmaceutical Services Business Description

Traded in Other Exchanges
Address
530 Herman O. West Drive, Exton, PA, USA, 19341-1147
West Pharmaceutical Services is based in Pennsylvania, US, and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), non-glass containment solutions, and auto-injectors for injectable drugs, which include large molecule biologics, peptides such as GLP-1 receptor agonists, and small molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.
Executives
Charles Witherspoon officer: VP & Treasurer 530 HERMAN O WEST DRIVE, EXTON PA 19341
Eric Mark Green officer: Chief Executive Officer 530 HERMAN O. WEST DRIVE, EXTON PA 19341
Silji Abraham officer: Chief Digital & Trans Officer 5000 TOWN CENTER, U, SOUTHFIELD MI 48075
Thomas W Hofmann director FIVE RADNOR CORPORATE CENTER, SUITE 500, RADNOR PA 19087
Chad Winters officer: VP, CAO & Controller 530 HERMAN O. WEST DRIVE, EXTON PA 19341
Annette F Favorite officer: Sr. VP Human Resources Officer 530 HERMAN O. WEST DRIVE, EXTON PA 19341
Cindy Reiss-clark officer: Senior Vice President 530 HERMAN O. WEST DRIVE, EXTON PA 19341-1147
Quintin J Lai officer: VP Corp Development & Strategy 530 HERMAN 0. WEST DRIVE, EXTON PA 19341
Bernard Birkett officer: Sr VP, CFO & Treasurer 1600 WEST MERIT PARKWAY, SOUTH JORDAN UT 84095
Stephen H Lockhart director C/O NATIONAL RESEARCH CORPORATION, 1245 Q STREET, LINCOLN NE 68508
Molly Joseph director 9209 GRAND SUMMIT BLVD, DRIPPING SPRINGS TX 78620
Kimberly Banks Mackay officer: SVP, GC & Corporate Secretary 530 HERMAN O. WEST DRIVE, EXTON PA 19341
George Lloyd Miller officer: Sr. VP, GC & Corp. Sec. 530 HERMAN O. WEST DRIVE, EXTON PA 19341
David A Montecalvo officer: SVP, Glob Ops and Supply Chain 530 HERMAN O. WEST DRIVE, EXTON PA 19341
Robert F Friel director 940 WINTER STREET, WALTHAM MA 02451

West Pharmaceutical Services Headlines

From GuruFocus